Clinical Trial: A Research Study Looking at How Safe Somapacitan is and How Well it Works in Children Who Need Help to Grow - REAL 9
Study Status: Completed
Recruit Status: RECRUITING
Condition: SGA
Study Type: INTERVENTIONAL
Official Title: A Study Evaluating the Safety and Efficacy of Once-weekly Dosing of Somapacitan in a Basket Study Design in Paediatric Participants With Short Stature Either Born Small for Gestational Age or With Tur
Brief Summary:
The purpose of this study is to find out if somapacitan is safe and how well somapacitan works in children either born small for gestational age or with Turner syndrome, Noonan syndrome or idiopathic short stature.Somapacitan is a new growth hormone medicine for treatment of low level of growth hormone.The study will last for about 3 years.During the study, the participants will be treated with somapacitan once a week.Somapacitan can be injected anytime during the day.The study doctor or nurse will show how to…
Read more